Analysis reveals variable GLP-1RA outcomes in obese adults, highlighting the need for further investigation.
In a large, diverse EHR cohort, GLP-1RA therapy was associated with significant weight, glycemic, and renal benefits that were attenuated in Black adults. These findings highlight the urgent need to understand mechanisms contributing to variable GLP-1RA outcomes among different populations.
No takes yet. Share an insight, caveat, or question.
Mallette et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: